IR

Aadi Bioscience to Participate in Jefferies London Healthcare Conference

Retrieved on: 
Monday, November 6, 2023
GMT, AADI, IR, Conference, Pharmaceutical industry, Online shopping, Vaccine

LOS ANGELES, Nov. 6, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced today participation in the Jefferies London Healthcare Conference, taking place November 14-16, 2023, in London.

Key Points: 
  • LOS ANGELES, Nov. 6, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced today participation in the Jefferies London Healthcare Conference, taking place November 14-16, 2023, in London.
  • Dave Lennon, Ph.D., President and CEO, will participate in a fireside chat on Tuesday, November 14, 2023, at 8:30 am GMT.
  • The fireside chat will be webcast live on the IR pages of the Aadi Bioscience website and will be available for replay for approximately 30 days following each investor event.

Key Digital® introduces KD-4KWHCEX wireless 4K HDMI extender

Retrieved on: 
Tuesday, October 31, 2023
Wi-Fi, TMDS, IR, MSRP, HDR10, AV, HDMI

MOUNT VERNON, NY, October 16, 2023 – Key Digital®, award-winning developer and manufacturer of leading-edge digital video processing and video signal distribution solutions, has introduced the KD-4KWHCEX HDMI 4K 60Hz 100 ft Wireless Extender KIT with IR.

Key Points: 
  • MOUNT VERNON, NY, October 16, 2023 – Key Digital®, award-winning developer and manufacturer of leading-edge digital video processing and video signal distribution solutions, has introduced the KD-4KWHCEX HDMI 4K 60Hz 100 ft Wireless Extender KIT with IR.
  • “The KD-4KWHCEX had a lot of enthusiastic response when we showed it recently at the CEDIA Tech Summit in Toronto,” says Key Digital VP of sales DeWayne Rains.
  • “It’s a product that solves a real-world problem by providing an effortless solution to HDMI extension in commercial installations and residential settings where running a wire is not possible.
  • Up to four extender sets using four unique channels are possible within the same operating area.

Banco Itaú Chile Announces Third Quarter 2023 Management Discussion & Analysis Report

Retrieved on: 
Tuesday, October 31, 2023
SSE, IR, Webcast, ID, Conference, NYSE, ITCL, Telephone, Internet service provider, Broadcasting

SANTIAGO, Chile, Oct. 31, 2023 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (NYSE: ITCL; SSE: ITAUCL) announced today its Management Discussion & Analysis Report (“MD&A Report”) for the third quarter ended September 30, 2023.

Key Points: 
  • SANTIAGO, Chile, Oct. 31, 2023 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (NYSE: ITCL; SSE: ITAUCL) announced today its Management Discussion & Analysis Report (“MD&A Report”) for the third quarter ended September 30, 2023.
  • For the full MD&A Report, please refer to the following link:
    On Monday, November 6, 2023, at 11:00 A.M. Santiago time (9:00 A.M.
  • ET), the Company’s management team will host a conference call to discuss the financial results.
  • The webcast can be found at:
    Webcast will be available on-demand via the same address as the live event afterwards.

Medallion Financial Corp. Reports 2023 Third Quarter Results

Retrieved on: 
Monday, October 30, 2023
IR, Medal, Bank, Ridesharing, Video game, Cryptocurrency, Holding company, Clothing, Agriculture, Real estate

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN, “Medallion” or the “Company”), a specialty finance company that originates and services loans in various consumer and commercial industries, along with offering loan origination services to fintech strategic partners, announced today its results for the quarter ended September 30, 2023.

Key Points: 
  • NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN, “Medallion” or the “Company”), a specialty finance company that originates and services loans in various consumer and commercial industries, along with offering loan origination services to fintech strategic partners, announced today its results for the quarter ended September 30, 2023.
  • Net interest income grew 13% to $35.6 million for the quarter, from $31.5 million in in the prior year quarter.
  • Net interest income grew 19% to $11.4 million for the quarter, from $9.6 million in the prior year quarter.
  • The Company will host a conference call to discuss its third quarter financial results tomorrow, Tuesday, October 31, 2023, at 9:00 a.m. Eastern time.

Ingersoll Rand Reports Record Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 1, 2023
Machinery, Machine Tools, Metalworking & Metallurgy, Other Manufacturing, Manufacturing, Adjustment, Vacuum, NYSE, Public expenditure, IR, Ingersoll Rand Industrial Technologies, Share repurchase, Order, Acquisition, Ingersoll Rand, IT&S, Growth, EPS, M&A, Machining, Lifting, Pharmaceutical industry, Retail, Fine chemical, Q3

Ingersoll Rand Inc. (NYSE: IR) reported record third quarter revenues.

Key Points: 
  • Ingersoll Rand Inc. (NYSE: IR) reported record third quarter revenues.
  • Ingersoll Rand remains in a strong financial position with ample liquidity of $3.2 billion.
  • Consistent with our comprehensive capital allocation strategy led by M&A, in the third quarter of 2023, Ingersoll Rand deployed $308 million to M&A.
  • Ingersoll Rand closed on the acquisition of Howden Roots LLC (“Roots”), a leading provider of low-pressure compression and vacuum technologies.

AUXLY TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON NOVEMBER 13, 2023

Retrieved on: 
Monday, November 6, 2023
IR, TSX, Drug, Bank

TORONTO, Nov. 6, 2023 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company"), a leading consumer packaged goods company in the cannabis products market, announced today that it will report earnings results for its third quarter 2023 ended September 30, 2023, on Monday, November 13, 2023, before the financial markets open.

Key Points: 
  • TORONTO, Nov. 6, 2023 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company"), a leading consumer packaged goods company in the cannabis products market, announced today that it will report earnings results for its third quarter 2023 ended September 30, 2023, on Monday, November 13, 2023, before the financial markets open.
  • The Company will not host an earnings conference call and the Company does not anticipate reinstating earnings conference calls until further notice.
  • All investor inquiries should be directed to [email protected] .

Q4 Inc. Recognized for Best Tech-Driven Capital Markets Platform and Most Innovative IR Website

Retrieved on: 
Monday, October 30, 2023
Professional Services, Technology, Finance, Software, Fintech, Banking, GBM, IR, Reuters - The World's Most Innovative Universities, Inc., TSX, Cryptocurrency, Q4

Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), the leading capital markets access platform, has been named the winner of two prestigious Global Brands Magazine Awards for Best Tech-Driven Capital Markets Platform and Most Innovative IR Website in Canada for 2023.

Key Points: 
  • Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), the leading capital markets access platform, has been named the winner of two prestigious Global Brands Magazine Awards for Best Tech-Driven Capital Markets Platform and Most Innovative IR Website in Canada for 2023.
  • Q4 was awarded for their exceptional commitment to innovation, quality, branding, customer service, and performance.
  • “We are honored to be recognized by Global Brands Magazine for the Best Tech-Driven Capital Markets Platform and Most Innovative IR Website,” remarked Darrell Heaps, Founder and CEO of Q4.
  • Built specifically for the speed, agility, and ever-evolving demands of IR, the Q4 Platform allows IR teams to easily communicate their company’s story and value with the capital markets.

New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy

Retrieved on: 
Friday, October 27, 2023
HKEX, IgA nephropathy, Sustainability, IR, Person, HIV disease progression rates, Macau Special Administrative Region passport, Priority review, Risk, CET, CALT, NDA, Hospital, Pharmaceutical industry, Mount Everest

The approval for Nefecon is for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression.

Key Points: 
  • The approval for Nefecon is for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression.
  • Macau is the first region in Everest territories that received Nefecon approval.
  • The NDA for Nefecon in mainland China is under Priority Review and Nefecon was the first non-oncology medicine to receive Breakthrough Therapy Designation in China.
  • Nefecon has been available for clinical use in Shanghai Ruijin Hospital's Hainan subsidiary through an early-access program since April 2023.

New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy

Retrieved on: 
Friday, October 27, 2023
HKEX, IgA nephropathy, Sustainability, IR, Person, HIV disease progression rates, Macau Special Administrative Region passport, Priority review, Risk, CET, CALT, NDA, Hospital, Pharmaceutical industry, Mount Everest

The approval for Nefecon is for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression.

Key Points: 
  • The approval for Nefecon is for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression.
  • Macau is the first region in Everest territories that received Nefecon approval.
  • The NDA for Nefecon in mainland China is under Priority Review and Nefecon was the first non-oncology medicine to receive Breakthrough Therapy Designation in China.
  • Nefecon has been available for clinical use in Shanghai Ruijin Hospital's Hainan subsidiary through an early-access program since April 2023.

The Joint Corp. to Host Conference Call on Thursday, November 9th to Discuss Third Quarter 2023 Results

Retrieved on: 
Thursday, October 26, 2023
IR, Joint

SCOTTSDALE, Ariz., Oct. 26, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its third quarter 2023 financial results on Thursday, November 9, 2023, after the market close.

Key Points: 
  • SCOTTSDALE, Ariz., Oct. 26, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its third quarter 2023 financial results on Thursday, November 9, 2023, after the market close.
  • President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.
  • The live webcast of the call with accompanying slide presentation can be accessed in the IR events section https://ir.thejoint.com/events and available for approximately one year.
  • An audio archive can be accessed for one week by dialing (877) 344-7529 or (412) 317-0088 and entering conference ID 7032664.